PPA
LJPC

Parametric Portfolio Associates’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Parametric Portfolio Associates’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,394
Closed -$94K – 4094
2020
Q1 		$94K Sell
22,394
-10,305
-32% -$65.1K ﹤0.01% 3742
2019
Q4 		$129K Buy
32,699
+17,112
+110% +$101K ﹤0.01% 3825
2019
Q3 		$137K Buy
15,587
+2,351
+18% +$22.2K ﹤0.01% 3777
2019
Q2 		$122K Buy
13,236
+2,693
+26% +$20.3K ﹤0.01% 3817
2019
Q1 		$68K Buy
+10,543
New +$68.7K ﹤0.01% 3858
2018
Q2 		– Sell
-16,467
Closed -$490K – 4088
2018
Q1 		$490K Buy
16,467
+863
+6% +$27.8K ﹤0.01% 3358
2017
Q4 		$502K Sell
15,604
-9,832
-39% -$321K ﹤0.01% 3320
2017
Q3 		$885K Buy
+25,436
New +$818K ﹤0.01% 3105

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Parametric Portfolio Associates's LJPC Position: Q2 2020 in Review

Parametric Portfolio Associates sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 22,394 shares — an estimated $94K sold.

Parametric Portfolio Associates first reported a position in LJPC in Q3 2017 and held it in 8 quarters. The position peaked at $885K in Q3 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Parametric Portfolio Associates reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 22,394 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $94K.
  • Parametric Portfolio Associates first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 8 quarters.
  • Parametric Portfolio Associates's La Jolla Pharmaceutical Company position peaked at $885K in Q3 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Parametric Portfolio Associates's 13F filing for Q2 2020, filed 13 Aug 2020.